Catalyst Wire Dossier Catalyst Wire Dossier

Nexavar

Sorafenib · Bayer
Drug timelines are a Plus or Pro feature.

240 regulatory and trial events tracked for Nexavar, covering 2007-03-05 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib

See pricing